NCT06621459
Retrospective Observational Study of the Safety and Toxicity Management of Abemaciclib in Combination with Adjuvant Hormone Therapy in Patients with RH+ ,HER2-nonoveramplified Breast Cancer, Real-life Data (MONARCHE29) No drug interventions Not Available Not Available recruiting NCT06344156
Neoantigen Vaccine Plus Anti-PD1 and Chemotherapy as an Adjuvant Therapy for Pancreatic Cancer No drug interventions treatment 1 recruiting NCT06581315
Postoperative Adjuvant Therapy of Donafenib for Hepatocellular Carcinoma treatment Not Available recruiting NCT01259934
Nordic Adjuvant IFN Melanoma Trial treatment 3 completed NCT05599334
A Retrospective Observational Study of Patients With Early-stage HER2-positive Breast Cancer, Treated With Neratinib No drug interventions Not Available Not Available recruiting NCT06361316
Irinotecan Liposome Combined With Oxaliplatin and Tegafur as Adjuvant Therapy for Pancreatic Cancer treatment Not Available recruiting NCT03958435
Real-world Retrospective Data Analysis of Adjuvant Therapy for Patients With Stage II-III Colon Cancer After Radical Surgery No drug interventions Not Available Not Available unknown_status NCT04981665
A Study to Evaluate TACE Sequential Tislelizumab as Adjuvant Therapy in Participants With HCC at High Risk of Recurrence After Curative Resection treatment 2 recruiting NCT04969029
Immunotherapy Versus Chemotherapy as Adjuvant Therapy for Colon Cancer With MSI-H or POLE/ POLD1 Mutations No drug interventions treatment 2 recruiting NCT05189067
Efficacy and Safety of Adjuvant Docetaxel and Trastuzumab in Stage I HER2-positive Breast Cancer treatment 2 / 3 recruiting NCT05161572
Perioperative Chemoimmunotherapy With/Without Preoperative Chemoradiation for Locally Advanced Gastric Cancer treatment 2 recruiting NCT05468138
PD-1 Antibody Adjuvant Therapy for GC Patients With MSI-H After D2 Radical Surgery No drug interventions treatment 2 not_yet_recruiting NCT05292742
Compare Continuation of Original Targeted Therapy With Trastuzumab Combined With Pyrotinib and Capecitabine as Postoperative Adjuvant Therapy in Non-pCR Patients With HER2 Positive Early Breast Cancer treatment 2 recruiting NCT05186506
A Study Comparing Ensatinib Versus Platinum-Based Chemotherapy as Adjuvant Treatment for Stage II-IIIA ALK -Positive Non-Small Cell Lung Cancer treatment 2 not_yet_recruiting NCT06056336
Perioperative Tislelizumab Plus Chemotherapy for Resectable Thoracic Oesophageal Squamous Cell Carcinoma treatment 2 recruiting NCT06461936
Intra-Tumoral Vascular Growth Patterns is a Robust Indicator of Adjuvant Therapy Following Liver Resection in HCC Not Available Not Available active_not_recruiting NCT05310318
Prognosis of Low-grade Endometrial Stromal Sarcoma No drug interventions Not Available Not Available recruiting NCT02301286
A Trial of Aspirin on Recurrence and Survival in Colon Cancer Patients treatment 3 active_not_recruiting NCT05111366
TQB2450 Plus Anlotinib as Adjuvant Therapy in HCC Patients at High Risk of Recurrence After Resection treatment 2 unknown_status NCT03963882
NAC Followed by RH for the Treatment of LACC No drug interventions treatment 2 recruiting NCT06041776
Adjuvant Befotertinib in Stage IB-IIIB Non-small Cell Lung Cancer With Positive EGFR Sensitive Mutations No drug interventions treatment 3 recruiting NCT04682210
Sintilimab Plus Bevacizumab as Adjuvant Therapy in HCC Patients at High Risk of Recurrence After Curative Resection treatment 3 not_yet_recruiting